Clinical Trial Update: Anti-thymocyte Globulins for Graft-versus-host Disease Prophylaxis [Phase 4]

View source ↗

Summary

Phase 4 trial update on anti-thymocyte globulins for graft-versus-host disease prophylaxis completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Graft-versus-host Disease
• Leukemia
• Transplantation

Snippet

Sponsor: Peking University People's Hospital | Conditions: Leukemia, GVHD, ATG, Transplantation | Phase 4 | Status: COMPLETED